ENLV
ENLV clinical trials: Enlivex Ltd.
Every trial on ClinicalTrials.gov where Enlivex Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 9
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ENLV on the catalyst calendar · ENLV registry changes
- Primary completion Mar 15, 2026ActualPhase 1/Phase 2NCT06233474Study of Intra-articular Allocetra in Knee OsteoarthritisEnlivex Therapeutics Ltd. · Osteoarthritis, KneeCompletedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimatePhase 2NCT07580716Intra-Articular Allocetra in Patients With Primary Knee OsteoarthritisEnlivex Therapeutics Ltd. · Primary Knee OsteoarthritisRecruitingENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 20, 2025ActualPhase 1NCT06522035Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic ArthritisEnlivex Therapeutics Ltd. · Arthritis, PsoriaticTerminatedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 12, 2024ActualPhase 2NCT04612413A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ...Enlivex Therapeutics Ltd. · SepsisCompletedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 15, 2024ActualPhase 1/Phase 2NCT05581719A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid...Enlivex Therapeutics RDO Ltd. · Solid TumorTerminatedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 14, 2024ActualPhase 1/Phase 2NCT05431907Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as...Enlivex Therapeutics RDO Ltd. · Peritoneal MetastasesTerminatedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2022ActualPhase 2NCT04922957A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients...Enlivex Therapeutics Ltd. · Covid19TerminatedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2022Sponsor estimatePhase 1NCT04659304Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19Enlivex Therapeutics Ltd. · Covid19Unknown statusENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 10, 2019ActualPhase 1NCT03925857Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTSEnlivex Therapeutics Ltd. · Organ Dysfunction Syndrome SepsisCompletedENLVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 25, 2026Sponsor estimateEarly Phase 1NCT06208241Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of SafetyAmir Oron · Knee OsteoarthritisActive, not recruitingENLVCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner